Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
A Bonney, R Malouf, C Marchal… - Cochrane Database …, 2022 - cochranelibrary.com
Background Lung cancer is the most common cause of cancer‐related death in the world,
however lung cancer screening has not been implemented in most countries at a population …
however lung cancer screening has not been implemented in most countries at a population …
中国恶性肿瘤流行情况及防控现状
曹毛毛, 陈万青 - 中国肿瘤临床, 2019 - cjco.cn
癌症是危害中国居民健康的疾病之一. 其每年发病数和死亡数分别占全球的23.7% 和30%.
由于人口老龄化, 工业化, 城市化进程的加剧, 生活方式的改变等原因, 中国癌症的发病数和死亡 …
由于人口老龄化, 工业化, 城市化进程的加剧, 生活方式的改变等原因, 中国癌症的发病数和死亡 …
Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis
KL Huang, SY Wang, WC Lu, YH Chang, J Su… - BMC pulmonary …, 2019 - Springer
Abstract Background The Nelson mortality results were presented in September 2018. Four
other randomized control trials (RCTs) were also reported the latest mortality outcomes in …
other randomized control trials (RCTs) were also reported the latest mortality outcomes in …
Knowledge-based collaborative deep learning for benign-malignant lung nodule classification on chest CT
The accurate identification of malignant lung nodules on chest CT is critical for the early
detection of lung cancer, which also offers patients the best chance of cure. Deep learning …
detection of lung cancer, which also offers patients the best chance of cure. Deep learning …
Modeled reductions in late-stage cancer with a multi-cancer early detection test
Background: Cancer is the second leading cause of death globally, with many cases
detected at a late stage when prognosis is poor. New technologies enabling multi-cancer …
detected at a late stage when prognosis is poor. New technologies enabling multi-cancer …
Diagnostic and therapeutic delays in patients with hepatocellular carcinoma
Background: Delays in diagnosis and treatment have been reported for many cancers, with
resultant stage migration and worse survival; however, few data exist in patients with …
resultant stage migration and worse survival; however, few data exist in patients with …
[PDF][PDF] Low-dose computed tomography for lung cancer screening in high risk populations: a systematic review and economic evaluation
Background Diagnosis of lung cancer frequently occurs in its later stages. Low-dose
computed tomography (LDCT) could detect lung cancer early. Objectives To estimate the …
computed tomography (LDCT) could detect lung cancer early. Objectives To estimate the …
[HTML][HTML] Hesitancy around low-dose CT screening for lung cancer
JL Dickson, C Horst, A Nair, S Tisi, R Prendecki… - Annals of …, 2022 - Elsevier
Lung cancer is the leading cause of cancer death worldwide. The absence of symptoms in
early-stage (I/II) disease, when curative treatment is possible, results in> 70% of cases being …
early-stage (I/II) disease, when curative treatment is possible, results in> 70% of cases being …
Current and future perspectives on computed tomography screening for lung cancer: a roadmap from 2023 to 2027 from the International Association for the Study of …
S Lam, C Bai, DR Baldwin, Y Chen, C Connolly… - Journal of Thoracic …, 2024 - Elsevier
Low-dose computed tomography (LDCT) screening for lung cancer substantially reduces
mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses …
mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses …
The present and future of liquid biopsies in non-small cell lung cancer: combining four biosources for diagnosis, prognosis, prediction, and disease monitoring
JWP Bracht, C Mayo-de-Las-Casas, J Berenguer… - Current Oncology …, 2018 - Springer
Abstract Purpose of Review Liquid biopsies have potential as tools for diagnosis, prognosis,
and prediction of response to therapy. Herein, we will extensively review four liquid …
and prediction of response to therapy. Herein, we will extensively review four liquid …